Brent L. Saunders - 29 Dec 2021 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Yi Ching Yau, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
29 Dec 2021
Net transactions value
+$254,880
Form type
4
Filing time
03 Jan 2022, 18:59:33 UTC
Previous filing
15 Dec 2021
Next filing
31 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Purchase $254,880 +17,600 $14.48 17,600 29 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price of the shares purchased from $14.45 to $14.49 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in this footnote.